Shedding light on the retina to see healthy and pathological aging.

Mar��lia In��s M��vio, Maria Camila Almeida, Sergio T Ferreira, Alexandre Hiroaki Kihara
Author Information
  1. Mar��lia In��s M��vio: Neurogenetics Laboratory, Federal University of ABC, S��o Bernardo do Campo, SP, Brazil (M��vio MI, Kihara AH).
  2. Maria Camila Almeida: Center for Natural and Human Sciences, Federal University of ABC, Sao Bernardo do Campo, SP, Brazil (Almeida MC).
  3. Sergio T Ferreira: Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil (Ferreira ST).
  4. Alexandre Hiroaki Kihara: Neurogenetics Laboratory, Federal University of ABC, S��o Bernardo do Campo, SP, Brazil (M��vio MI, Kihara AH). ORCID

Abstract

No abstract text available.

References

  1. Adhikari S, Qiao Y, Singer M, Sagare A, Jiang X, Shi Y, Ringman JM, Kashani AH (2023) Retinotopic degeneration of the retina and optic tracts in autosomal dominant Alzheimer���s disease. Alzheimers Dement 19:5103���5113.
  2. Almeida MC, Eger SJ, He C, Audouard M, Nikitina A, Glasauer SMK, Han D, Mejia-Cupajita B, Acosta-Uribe J, Villalba-Moreno ND, Littau JL, Elcheikhali M, Rivera EK, Carrettiero DC, Villegas-Lanau CA, Sepulveda-Falla D, Lopera F, Kosik KS (2024) Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer���s disease profile and possible mechanisms of disease protection. Neuron 112:1778���1794.
  3. Asanad S, Felix CM, Fantini M, Harrington MG, Sadun AA, Karanjia R (2021) Retinal ganglion cell dysfunction in preclinical Alzheimer���s disease: an electrophysiologic biomarker signature. Sci Rep 11:6344.
  4. Ashayeri H, Jafarizadeh A, Yousefi M, Farhadi F, Javadzadeh A (2024) Retinal imaging and Alzheimer���s disease: a future powered by artificial intelligence. Graefes Arch Clin Exp Ophthalmol 262:2389���2401.
  5. Bovi Dos Santos G, de Lima-Vasconcellos TH, Movio MI, Birbrair A, Del Debbio CB, Kihara AH (2024) New perspectives in stem cell transplantation and associated therapies to treat retinal diseases: from gene editing to 3D bioprinting. Stem Cell Rev Rep 20:722���737.
  6. Casciano F, Zauli E, Celeghini C, Caruso L, Gonelli A, Zauli G, Pignatelli A (2024) Retinal alterations predict early prodromal signs of neurodegenerative disease. Int J Mol Sci 25:1689.
  7. Koronyo Y, et al. (2023) Retinal pathological features and proteome signatures of Alzheimer���s disease. Acta Neuropathol 145:409���438.
  8. Movio MI, de Lima-Vasconcellos TH, Dos Santos GB, Echeverry MB, Colombo E, Mattos LS, Resende RR, Kihara AH (2023) Retinal organoids from human-induced pluripotent stem cells: from studying retinal dystrophies to early diagnosis of Alzheimer���s and Parkinson���s disease. Semin Cell Dev Biol 144:77���86.
  9. Palmqvist S, Tideman P, Mattsson-Carlgren N, Schindler SE, Smith R, Ossenkoppele R, Calling S, West T, Monane M, Verghese PB, Braunstein JB, Blennow K, Janelidze S, Stomrud E, Salvado G, Hansson O (2024) Blood biomarkers to detect Alzheimer disease in primary care and secondary care. JAMA doi: 10.1001/jama.2024.13855.
  10. Parmar UPS, Surico PL, Singh RB, Romano F, Salati C, Spadea L, Musa M, Gagliano C, Mori T, Zeppieri M (2024) Artificial intelligence (AI) for early diagnosis of retinal diseases. Medicina (Kaunas) 60:527.
  11. Sheriff S, Shen T, Abdal S, Saks D, Mirzaei M, Gupta V, Chitranshi N, You Y, Schultz A, Graham SL, Gupta V (2023) Retinal thickness and vascular parameters using optical coherence tomography in Alzheimer���s disease: a meta-analysis. Neural Regen Res 18:2504���2513.
  12. Wagner SK, et al. (2023) Retinal optical coherence tomography features associated with incident and prevalent parkinson disease. Neurology 101:e1581-1593.

Word Cloud

Created with Highcharts 10.0.0Sheddinglightretinaseehealthypathologicalaging

Similar Articles

Cited By

No available data.